3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Kimura's disease and ankylosing spondylitis : A case report

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rationale:

          Ankylosing spondylitis (AS) and Kimura's disease (KD) which is quite rare are both chronic inflammatory diseases. Recently we encountered a patient who suffered from KD and AS, and some of his family members also suffer from AS. We, therefore, investigated this unique case and conducted the family-based whole exome sequencing to explore the possible genetic alterations.

          Patient concerns:

          Here, we reported a case of a 44-year-old Chinese man with multiple painless masses all over his body and a back pain for 32 years. His uncle and sister were diagnosed with AS.

          Diagnosis:

          The diagnosis of KD was based on the patient's clinical features and the biopsy of the neck masses. The diagnosis of AS was based on the patient's clinical features, HLA-B27(+) and the radiologic changes of sacroiliac joints. The genetic test showed that ARPC1B gene which was associated with recurrent infections, auto-inflammatory changes and elevated IgE levels was mutated in this patient.

          Interventions:

          Neck masses were removed by surgery. Systemic glucocorticoid, nonsteroidal anti-inflammatory agents, combined with cyclosporine were orally administered, and Etanercept was injected subcutaneously.

          Outcomes:

          The masses disappeared rapidly after surgery combined with systemic glucocorticoid, but relapsed shortly after the therapy was discontinued. Low dose glucocorticoid, cyclosporine and Etanercept could keep both KD and AS remained long-term remission.

          Lessons:

          Our experience suggests that low dose glucocorticoid, cyclosporine and Etanercept could be beneficial for the patient with KD and AS. The mutation of ARPC1B gene in this case, which is associated with immunologic disturbance, may increase the susceptibility of KD.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          Pathogenesis of ankylosing spondylitis — recent advances and future directions

          In this Review, the authors discuss the latest insights into the genetic associations and pathological mechanisms of ankylosing spondylitis, in particular HLA-B27-mediated pathology, antigen-presentation pathways and the role of type 3 immunity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Role of HLA-B27 in the pathogenesis of ankylosing spondylitis

            The study of ankylosing spondylitis (AS) has made significant progress over the last decade. Genome-wide association studies have identified and further substantiated the role of susceptibility genes outside the major histocompatibility complex locus. However, human leukocyte antigen (HLA)-B27 has been suggested to be important in the pathogenesis of AS, contributing to ~20.1% of AS heritability. The current review will present the classical and non-classical forms of HLA-B27, as well as their pathogenic roles, and further discuss the hypotheses regarding the potential pathogenesis of AS. In addition, the association between the pathogenic role of HLA-B27 and inflammatory indexes, including the interleukin-23/−17 axis will be investigated to provide novel insights into the pathogenesis of AS. The aim of the present review is to provide an update of the current research into the pathogenesis of AS, and provide a comprehensive description of the pathogenic role of HLA-B27 in AS.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              T cell defects in patients with ARPC1B germline mutations account for their combined immunodeficiency

              ARPC1B is a key factor for the assembly and maintenance of the ARP2/3 complex that is involved in actin branching from an existing filament. Germline biallelic mutations in ARPC1B have been recently described in 6 patients with clinical features of combined immunodeficiency (CID), whose neutrophils and platelets but not T lymphocytes were studied. We hypothesized that ARPC1B deficiency may also lead to cytoskeleton and functional defects in T cells. We have identified biallelic mutations in ARPC1B in 6 unrelated patients with early onset disease characterized by severe infections, autoimmune manifestations, and thrombocytopenia. Immunological features included T-cell lymphopenia, low numbers of naïve T cells, and hyper-immunoglobulin E. Alteration in ARPC1B protein structure led to absent/low expression by flow cytometry and confocal microscopy. This molecular defect was associated with the inability of patient-derived T cells to extend an actin-rich lamellipodia upon T-cell receptor (TCR) stimulation and to assemble an immunological synapse. ARPC1B-deficient T cells additionally displayed impaired TCR-mediated proliferation and SDF1-α-directed migration. Gene transfer of ARPC1B in patients' T cells using a lentiviral vector restored both ARPC1B expression and T-cell proliferation in vitro. In 2 of the patients, in vivo somatic reversion restored ARPC1B expression in a fraction of lymphocytes and was associated with a skewed TCR repertoire. In 1 revertant patient, memory CD8+ T cells expressing normal levels of ARPC1B displayed improved T-cell migration. Inherited ARPC1B deficiency therefore alters T-cell cytoskeletal dynamics and functions, contributing to the clinical features of CID.
                Bookmark

                Author and article information

                Journal
                Medicine (Baltimore)
                Medicine (Baltimore)
                MEDI
                Medicine
                Lippincott Williams & Wilkins (Hagerstown, MD )
                0025-7974
                1536-5964
                21 August 2020
                21 August 2020
                : 99
                : 34
                : e21629
                Affiliations
                [a ]Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan
                [b ]Key Laboratory of Hubei Provincial of Occurrence and Intervention of Rheumatic Diseases, Affiliated Minda Hospital, Hubei National University, Enshi, Hubei, China.
                Author notes
                []Correspondence: Yi Liu, Department of Rheumatology and Immunology, West China Hospital, Sichuan University, 37 Guoxue Xiang, Chengdu, Sichuan 610041, China (e-mail: yi2006liu@ 123456163.com ).
                Author information
                http://orcid.org/0000-0001-9366-1825
                Article
                MD-D-19-08886 21629
                10.1097/MD.0000000000021629
                7447461
                32846771
                a50d3f73-d29a-4c21-8c71-6df506480a95
                Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.

                This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0

                History
                : 23 November 2019
                : 21 March 2020
                : 9 July 2020
                Funding
                Funded by: National Key Research and Development Program of China
                Award ID: 2016YFC0906201
                Award Recipient : Yi Liu
                Funded by: West China Hospital, Sichuan University
                Award ID: ZYGD18015
                Award Recipient : Yi Liu
                Funded by: project for disciplines of excellence, West China Hospital,Sichuan University
                Award ID: ZYJC18003
                Award Recipient : Yi Liu
                Categories
                4200
                Research Article
                Clinical Case Report
                Custom metadata
                TRUE

                ankylosing spondylitis,arpc1b gene,cyclosporine,etanercept,kimura's disease

                Comments

                Comment on this article